Regarding that cognitive impairment may occur in type 2 diabetes patients and that ghrelin also modulates insulin sensitivity (Barazzoni et al., 2008), administration of the peptide to diabetes patients might have a clinical relevance in cognitive behavior recovery (McNay, 2007). The gene discussed is GHRL; the disease is Cognitive impairment.